| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | -$295.57M | -$82.13M | $68.76M | -$61.31M | -$125.83M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $14.11M | -$4.57M | -$1.41M | -$1.04M | $1.12M |
| Net Income | -$309.68M | -$77.56M | $70.17M | -$60.27M | -$126.95M |
| EPS (basic) | -0.5300 | -0.1400 | 0.1600 | – | – |
| EPS (diluted) | -0.5300 | -0.1400 | 0.1600 | – | – |
| Shares (diluted) | $588.40M | $554.76M | $529.21M | – | – |